Oldfield Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-14,603
Closed -$1.58M 24
2017
Q1
$1.58M Buy
+14,603
New +$1.74M 0.14% 15
2016
Q2
Sell
-14,603
Closed -$1.58M 22
2016
Q1
$1.58M Hold
14,603
0.13% 15
2015
Q4
$1.02M Hold
14,603
0.09% 17
2015
Q3
$1.36M Hold
14,603
0.1% 16
2015
Q2
$1.42M Hold
14,603
0.08% 17
2015
Q1
$1.47M Sell
14,603
-1,500
-9% -$153K 0.09% 15
2014
Q4
$1.68M Sell
16,103
-2,100
-12% -$221K 0.1% 16
2014
Q3
$1.94M Hold
18,203
0.11% 16
2014
Q2
$1.9M Hold
18,203
0.08% 17
2014
Q1
$1.79M Hold
18,203
0.09% 17
2013
Q4
$1.01M Hold
18,203
0.05% 17
2013
Q3
$1.58M Sell
18,203
-11,600
-39% -$1.04M 0.08% 16
2013
Q2
$2.56M Buy
+29,803
New +$2.53M 0.17% 17

Other funds holding JNJ

Oldfield Partners's JNJ Position: Q2 2017 in Review

Oldfield Partners sold out of Johnson & Johnson (JNJ) in Q2 2017, closing a stake of 14,603 shares — an estimated $1.58M sold.

Oldfield Partners first reported a position in JNJ in Q2 2013 and held it in 13 quarters. The position peaked at $2.56M in Q2 2013. 2,350 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

  • Oldfield Partners reported no remaining Johnson & Johnson position as of Q2 2017 after selling out during the quarter.
  • Oldfield Partners sold 14,603 Johnson & Johnson shares in Q2 2017, an estimated $1.58M.
  • Oldfield Partners first reported a position in Johnson & Johnson in Q2 2013 and held it in 13 quarters.
  • Oldfield Partners's Johnson & Johnson position peaked at $2.56M in Q2 2013.
  • 2,350 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Oldfield Partners's 13F filing for Q2 2017, filed 21 Jul 2017.